Literature DB >> 15711925

Evidence in favour of a role for peripheral-type benzodiazepine receptor ligands in amplification of neuronal apoptosis.

E G Jordà1, A Jiménez, E Verdaguer, A M Canudas, J Folch, F X Sureda, A Camins, M Pallàs.   

Abstract

The mitochondrial peripheral benzodiazepine receptor (PBR) is involved in a functional structure designated as the mitochondrial permeability transition (MPT) pore, which controls apoptosis. PBR expression in nervous system has been reported in glial and immune cells. We now show expression of both PBR mRNA and protein, and the appearance of binding of a synthetic ligand fluo-FGIN-1-27 in mitochondria of rat cerebellar granule cells (CGCs). Additionally, the effect of PBR ligands on colchicine-induced apoptosis was investigated. Colchicine-induced neurotoxicity in CGCs was measured at 24 h. We show that, in vitro, PBR ligands 1-(2-chlorophenyl-N-methylpropyl)-3-isoquinolinecarboxamide (PK11195), 7-chloro-5-(4-chlorophenyl)-1,3-dihydro-1-methyl-2H-1,4- benzodiazepin-2-one (Ro5-4864) and diazepam (25- 50 microM) enhanced apoptosis induced by colchicine, as demonstrated by viability experiments, flow cytometry and nuclear chromatin condensation. Enhancement of colchicine-induced apoptosis was characterized by an increase in mitochondrial release of cytochrome c and AIF proteins and an enhanced activation of caspase-3, suggesting mitochondrion dependent mechanism that is involved in apoptotic process. Our results indicate that exposure of neural cells to PBR ligands generates an amplification of apoptotic process induced by colchicine and that the MPT pore may be involved in this process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15711925     DOI: 10.1007/s10495-005-6064-9

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  12 in total

1.  Translocator protein 18 kDa negatively regulates inflammation in microglia.

Authors:  Keun-Ryung Bae; Hyun-Jung Shim; Deebika Balu; Sang Ryong Kim; Seong-Woon Yu
Journal:  J Neuroimmune Pharmacol       Date:  2014-04-01       Impact factor: 4.147

Review 2.  Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy.

Authors:  Burkhard Poeggeler
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 3.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.

Authors:  Rainer Rupprecht; Vassilios Papadopoulos; Gerhard Rammes; Thomas C Baghai; Jinjiang Fan; Nagaraju Akula; Ghislaine Groyer; David Adams; Michael Schumacher
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

4.  Gene expression in the rat brain during prostaglandin D2 and adenosinergically-induced sleep.

Authors:  Akira Terao; Zhi-Li Huang; Jonathan P Wisor; Takatoshi Mochizuki; Dmitry Gerashchenko; Yoshihiro Urade; T S Kilduff
Journal:  J Neurochem       Date:  2008-03-07       Impact factor: 5.372

5.  Design and rationale of the "Sedation strategy and cognitive outcome after critical illness in early childhood" study.

Authors:  Martha A Q Curley; R Scott Watson; Amy M Cassidy; Cheryl Burns; Rachel L Delinger; Derek C Angus; Lisa A Asaro; David Wypij; Sue R Beers
Journal:  Contemp Clin Trials       Date:  2018-07-11       Impact factor: 2.226

6.  Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18 kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibition.

Authors:  Ana Agusti; Jennifer L Dziedzic; Vicente Hernandez-Rabaza; Tomas R Guilarte; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2013-12-04       Impact factor: 3.584

7.  Combined effect of G3139 and TSPO ligands on Ca(2+)-induced permeability transition in rat brain mitochondria.

Authors:  T Azarashvili; O Krestinina; Yu Baburina; I Odinokova; D Grachev; V Papadopoulos; V Akatov; J J Lemasters; G Reiser
Journal:  Arch Biochem Biophys       Date:  2015-10-20       Impact factor: 4.013

8.  Effect of ZBD-2 on chronic pain, depressive-like behaviors, and recovery of motor function following spinal cord injury in mice.

Authors:  Xiao-Ming Li; Jia Meng; Lin Tao Li; Ting Guo; Liu-Kun Yang; Qi-Xin Shi; Xu-Bo Li; Yong Chen; Qi Yang; Jian-Ning Zhao
Journal:  Behav Brain Res       Date:  2017-01-18       Impact factor: 3.332

Review 9.  Translocator protein (18 kDa): a promising therapeutic target and diagnostic tool for cardiovascular diseases.

Authors:  Xiaolong Qi; Jiahong Xu; Fei Wang; Junjie Xiao
Journal:  Oxid Med Cell Longev       Date:  2012-11-28       Impact factor: 6.543

10.  Quantifying the A1AR distribution in peritumoural zones around experimental F98 and C6 rat brain tumours.

Authors:  Markus Dehnhardt; Christoph Palm; Andrea Vieten; Andreas Bauer; Uwe Pietrzyk
Journal:  J Neurooncol       Date:  2007-05-12       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.